Increased serum neopterin: A marker of coronary artery disease activity in women

Heart

Volumn 83, Issue 3, 2000, Pages 346-350

  Garcia Moll, X ^a   Cole, D ^a   Zouridakis, E ^a   Kaski, J C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Coronary artery disease; Neopterin; Women

Indexed keywords

NEOPTERIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE ACTIVITY; DISEASE MARKER; ELECTROCARDIOGRAM; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

EID: 0034022382     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.3.346     Document Type: Article

References (31)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
2. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31:1217-25.
3. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994;90:775-8.
4. van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
5. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
6. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984;160:310-6.
7. Schobersberger W, Hoffmann G, Grote J, et al. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Lett 1995;377:461-4.
8. Werner-Felmayer G, Werner ER, Fuchs D, et al. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem 1993;268:1842-6.
9. Wirleitner B, Baier-Bitterlich G, Hoffmann G, et al. Neopterin activates transcription factor nuclear factor-kappa B in vascular smooth muscle cells. FEBS Lett 1996;391:181-4.
10. Barnes PJ, Karin M. Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
11. Thurberg BL, Collins T. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 1998,9:387-96.
12. Tatzber F, Rabl H, Koriska K, et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 1991;89:203-8.
13. Weiss G, Willeit J, Kiechl S, et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 1994;106:263-71.
14. Gupta S, Fredericks S, Schwartzman RA, et al. Serum neopterin in acute coronary syndromes [research letter]. Lancet 1997;349:1252.
15. Schumacher M, Halwachs G, Tatzber F, et al. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997;30:703-7.
16. Gurfinkel EP, Scirica BM, Bozovich G, et al. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q wave acute myocardial infarction. Am J Cardiol 1999;83:515-8.
17. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-14.
18. Ischaemic Heart Disease Registers. Report of the fifth working group convened by the Regional Office for Europe of the World Health Organization. Copenhagen, April 1971. Regional Office for Europe, WHO.
19. Werner ER, Bichler A, Daxenbichler G, et al. Determination of neopterin in serum and urine. Clin Chem 1987;33:62-6.
20. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
21. van der Wal AC, Becker AE, Koch KT, et al. Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques. Heart 1996;76:312-16.
22. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
23. Neri Serneri GG, Prisco D, Martini F, et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95:1806-12.
24. Neri Serneri GG, Abbate R, Gori AM, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992;86:790-7.
25. Hoffmann G, Schobersberger W, Frede S, et al. Neopterin activates transcription factor nuclear factor-kappa B in vascular smooth muscle cells. FEBS Lett 1996;391:181-4.
26. Ritchie ME. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998;98:1707-13.
27. Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996;97:1715-22.
28. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 1993;68:499-508.
29. De Servi S, Mazzone A, Ricevuti G, et al. Clinical and angiographic correlates of leukocyte activation in unstable angina. J Am Coll Cardiol 1995;26:1146-50.
30. Caligiuri G, Liuzzo G, Biasucci LM, et al. Immune system activation follows inflammation in unstable angina: pathogenetic implications. J Am Coll Cardiol 1998;32:1295-304.
31. Kaski JC. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1998;31:523-6.